Literature DB >> 33526913

Assessment of nephron number and single-nephron glomerular filtration rate in a clinical setting.

Nobuo Tsuboi1, Takaya Sasaki2, Yusuke Okabayashi2, Kotaro Haruhara2, Go Kanzaki2, Takashi Yokoo2.   

Abstract

Total nephron counts vary widely between individuals and may affect susceptibility to certain diseases, including hypertension and chronic kidney disease. Detailed analyses of whole kidneys collected from autopsy patients remain the only method for accurately counting nephrons in humans, with no equivalent option in living subjects. Current technological advances have enabled estimations of nephron numbers in vivo, particularly the use of total nephron number and whole-kidney glomerular filtration rate to estimate the mean single-nephron glomerular filtration rate. The use of this method would allow physicians to detect dynamic changes in filtration function at the single-nephron level rather than to simply count the number of nephrons that appear to be functioning. Currently available methods for estimating total nephron number in clinical practice have the potential to overcome limitations associated with autopsy analyses and may therefore pave the way for new therapeutic interventions and improved clinical outcomes.

Entities:  

Keywords:  CKD; Hypertension; Kidney biopsy; Kidney cortical volume; Nephron number; Single-nephron GFR

Mesh:

Year:  2021        PMID: 33526913     DOI: 10.1038/s41440-020-00612-y

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  121 in total

Review 1.  Stereologic methods and their application in kidney research.

Authors:  J R Nyengaard
Journal:  J Am Soc Nephrol       Date:  1999-05       Impact factor: 10.121

Review 2.  Counting in the kidney.

Authors:  J F Bertram
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

3.  Low birthweight and renal disease in Australian aborigines.

Authors:  W E Hoy; M Rees; E Kile; J D Mathews; D A McCredie; D J Pugsley; Z Wang
Journal:  Lancet       Date:  1998-12-05       Impact factor: 79.321

4.  Renal biopsy findings among Indigenous Australians: a nationwide review.

Authors:  Wendy E Hoy; Terence Samuel; Susan A Mott; Priscilla S Kincaid-Smith; Agnes B Fogo; John P Dowling; Michael D Hughson; Rajalingam Sinniah; David J Pugsley; Meshach G Kirubakaran; Rebecca N Douglas-Denton; John F Bertram
Journal:  Kidney Int       Date:  2012-08-29       Impact factor: 10.612

5.  Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis.

Authors:  A Fogo; E P Hawkins; P L Berry; A D Glick; M L Chiang; R C MacDonell; I Ichikawa
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

6.  Estimating total nephron number in the adult kidney using the physical disector/fractionator combination.

Authors:  Luise A Cullen-McEwen; Rebecca N Douglas-Denton; John F Bertram
Journal:  Methods Mol Biol       Date:  2012

7.  Glomerular hypertrophy as a prognostic marker in childhood IgA nephropathy.

Authors:  T Tóth; S Takebayashi
Journal:  Nephron       Date:  1998-11       Impact factor: 2.847

8.  Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis.

Authors:  Jeffrey B Hodgin; Majid Rasoulpour; Glen S Markowitz; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-19       Impact factor: 8.237

Review 9.  Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies.

Authors:  Sarah L White; Vlado Perkovic; Alan Cass; Choon Lan Chang; Neil R Poulter; Tim Spector; Leigh Haysom; Jonathan C Craig; Isa Al Salmi; Steven J Chadban; Rachel R Huxley
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Clinicopathological assessment of the nephron number.

Authors:  Nobuo Tsuboi; Go Kanzaki; Kentaro Koike; Tetsuya Kawamura; Makoto Ogura; Takashi Yokoo
Journal:  Clin Kidney J       Date:  2014-03-11
View more
  4 in total

1.  Estimating Nephron Number from Biopsies: Impact on Clinical Studies.

Authors:  Darya Morozov; Neda Parvin; Mark Conaway; Gavin Oxley; Edwin J Baldelomar; Aleksandra Cwiek; Kim deRonde; Scott C Beeman; Jennifer R Charlton; Kevin M Bennett
Journal:  J Am Soc Nephrol       Date:  2021-11-10       Impact factor: 10.121

Review 2.  Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection.

Authors:  Kotaro Haruhara; Go Kanzaki; Nobuo Tsuboi
Journal:  Hypertens Res       Date:  2022-10-12       Impact factor: 5.528

Review 3.  Healthy and unhealthy aging on kidney structure and function: human studies.

Authors:  Aleksandar Denic; Andrew D Rule; Richard J Glassock
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-01-25       Impact factor: 3.416

Review 4.  Update on Hypertension Research in 2021.

Authors:  Masaki Mogi; Tatsuya Maruhashi; Yukihito Higashi; Takahiro Masuda; Daisuke Nagata; Michiaki Nagai; Kanako Bokuda; Atsuhiro Ichihara; Yoichi Nozato; Ayumi Toba; Keisuke Narita; Satoshi Hoshide; Atsushi Tanaka; Koichi Node; Yuichi Yoshida; Hirotaka Shibata; Kenichi Katsurada; Masanari Kuwabara; Takahide Kodama; Keisuke Shinohara; Kazuomi Kario
Journal:  Hypertens Res       Date:  2022-07-05       Impact factor: 5.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.